Likewise, mutations in RNF43 and ZNRF3 have been reported in altered lipid metabolism, specifically in unsaturated fatty acids, acyl-CoA biosynthesis and non-alcoholic steatohepatitis (NASH) [30]. This evidence concerns the gene ZNRF3 and metabolic dysfunction-associated steatohepatitis.